Generation Bio Co. (GBIO)

Generation Bio Co. Statistics

Total Valuation

GBIO has a market cap or net worth of $88.17 million. The enterprise value is -$15.86 million.

Market Cap	88.17M
Enterprise Value	-15.86M

Important Dates

The last earnings date was Wednesday, November 6, 2024, after market close.

Earnings Date	Nov 6, 2024
Ex-Dividend Date	n/a

Share Statistics

GBIO has 66.79 million shares outstanding. The number of shares has increased by 5.77% in one year.

Current Share Class	66.79M
Shares Outstanding	66.79M
Shares Change (YoY)	+5.77%
Shares Change (QoQ)	+0.31%
Owned by Insiders (%)	5.74%
Owned by Institutions (%)	71.32%
Float	48.82M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.83
Forward PS	22.96
PB Ratio	0.86
P/TBV Ratio	0.86
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.34, with a Debt / Equity ratio of 0.90.

Current Ratio	6.34
Quick Ratio	6.20
Debt / Equity	0.90
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -86.50% and return on invested capital (ROIC) is -23.85%.

Return on Equity (ROE)	-86.50%
Return on Assets (ROA)	-19.29%
Return on Capital (ROIC)	-23.85%
Revenue Per Employee	$106,793
Profits Per Employee	-$836,046
Employee Count	174
Asset Turnover	0.06
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +18.94% in the last 52 weeks. The beta is 2.82, so GBIO's price volatility has been higher than the market average.

Beta (5Y)	2.82
52-Week Price Change	+18.94%
50-Day Moving Average	2.29
200-Day Moving Average	2.76
Relative Strength Index (RSI)	23.98
Average Volume (20 Days)	161,598

Short Selling Information

The latest short interest is 1.66 million, so 2.48% of the outstanding shares have been sold short.

Short Interest	1.66M
Short Previous Month	1.74M
Short % of Shares Out	2.48%
Short % of Float	3.40%
Short Ratio (days to cover)	17.16

Income Statement

In the last 12 months, GBIO had revenue of $18.58 million and -$145.47 million in losses. Loss per share was -$2.19.

Revenue	18.58M
Gross Profit	-41.44M
Operating Income	-97.27M
Pretax Income	-158.43M
Net Income	-145.47M
EBITDA	-92.19M
EBIT	-97.27M
Loss Per Share	-$2.19

Balance Sheet

The company has $184.77 million in cash and $93.78 million in debt, giving a net cash position of $106.03 million or $1.59 per share.

Cash & Cash Equivalents	184.77M
Total Debt	93.78M
Net Cash	106.03M
Net Cash Per Share	$1.59
Equity (Book Value)	104.44M
Book Value Per Share	1.56
Working Capital	161.09M

Cash Flow

In the last 12 months, operating cash flow was -$97.76 million and capital expenditures -$6.60 million, giving a free cash flow of -$104.36 million.

Operating Cash Flow	-97.76M
Capital Expenditures	-6.60M
Free Cash Flow	-104.36M
FCF Per Share	-$1.56

Margins

Gross Margin	-222.99%
Operating Margin	-523.47%
Pretax Margin	-782.87%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-835.92%

Dividends & Yields

GBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.77%
Shareholder Yield	-5.77%
Earnings Yield	-161.33%
FCF Yield	-115.74%

Analyst Forecast

The average price target for GBIO is $7.50, which is 468.18% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.50
Price Target Difference	468.18%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	13.14%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

GBIO has an Altman Z-Score of -3.58 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.58
Piotroski F-Score	3